Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology

ORCID: 0000-0002-1531-4294

Publication year:
All
1 - 25 out of 68Page size: 25
  1. 2022
  2. Published

    Endotrophin as a Marker of Complications in a Type 2 Diabetes Cohort

    Tougaard, N. H., Møller, A. L., Rønn, P. F., Hansen, T. W., Genovese, F., Karsdal, M. A., Rasmussen, D. G. K. & Rossing, Peter, Nov 2022, In: Diabetes Care. 45, 11, p. 2746-2748 3 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    The importance of addressing multiple risk markers in type 2 diabetes: Results from the LEADER and SUSTAIN 6 trials

    Zobel, E. H., von Scholten, B. J., Hansen, T. W., Persson, F., Rasmussen, S., Wolthers, B. & Rossing, Peter, Feb 2022, In: Diabetes, Obesity and Metabolism. 24, 2, p. 281-288 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    16-LB: Effects of Finerenone in Patients with CKD and T2D Are Independent of HbA1c at Baseline, HbA1c Variability, and Duration of Diabetes

    Mcgill, J. B., Agarwal, R., Anker, S., Bakris, G., Filippatos, G., Pitt, B., Ruilope, L. M., Birkenfeld, A. L., Caramori, L., Brinker, M. D., Joseph, A., Lage, A. Z., Lawatscheck, R., Scott, C. & Rossing, Peter, 2022, In: Diabetes. 71, Supplement_1, 16-LB.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  5. Published

    A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

    Heerspink, H. J. L. & DAPA-CKD Trial Committees and Investigators, D. T. C. A. I., 2022, In: Kidney International. 101, 1, p. 174-184 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Acute and Long-Term Treatment With Dapagliflozin and Association With Serum Soluble Urokinase Plasminogen Activator Receptor

    Rotbain Curovic, V., Houlind, Morten Baltzer, Hansen, T. W., Eugen-Olsen, J., Laursen, J. C., Eickhoff, M. K., Persson, F. & Rossing, Peter, 2022, In: Frontiers in Pharmacology. 13, 799915.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Association between plasma apolipoprotein M and cardiac autonomic neuropathy in type 1 diabetes

    Safi, M., Borup, A., Stevns Hansen, C., Rossing, Peter, Thorsten Jensen, M. & Christoffersen, Christina, 2022, In: Diabetes Research and Clinical Practice. 189, 7 p., 109943.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Association of Finerenone Use With Reduction in Treatment-Emergent Pneumonia and COVID-19 Adverse Events Among Patients With Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Pooled Secondary Analysis

    Pitt, B., Agarwal, R., Anker, S. D., Ruilope, L. M., Rossing, Peter, Ahlers, C., Brinker, M., Joseph, A., Lambelet, M., Lawatscheck, R. & Filippatos, G. S., 2022, In: JAMA network open. 5, 10, 10 p., E2236123.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Baseline risk markers and visit-to-visit variability in relation to kidney outcomes - A post-hoc analysis of the PERL study

    Curovic, V. R., Roy, N., Hansen, T. W., Caramori, M. L., Cherney, D. Z., Boer, I. H. D., Emanuele, M. A., Hirsch, I. B., Lingvay, I., Mcgill, J. B., Polsky, S., Pop-Busui, R., Sigal, R. J., Tuttle, K. R., Umpierrez, G. E., Wallia, A., Rosas, S. E. & Rossing, Peter, 2022, In: Diabetes Research and Clinical Practice. 193, 8 p., 110119.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes

    Ruilope, L. M., Agarwal, R., Anker, S. D., Filippatos, G., Pitt, B., Rossing, Peter, Sarafidis, P., Schmieder, R. E., Joseph, A., Rethemeier, N., Nowack, C., Bakris, G. L. & the FIDELIO-DKD Investigators, T. F. I., 2022, In: Hypertension. 79, 12, p. 2685-2695 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Cardiovascular Autonomic Neuropathy in Type 1 Diabetes Is Associated With Disturbances in TCA, Lipid, and Glucose Metabolism

    Hansen, C. S., Suvitaival, T., Theilade, Karen Simone, Mattila, I., Lajer, M., Trošt, K., Ahonen, L., Hansen, T. W., Legido-Quigley, C., Rossing, Peter & Ahluwalia, Tarun Veer Singh, 2022, In: Frontiers in Endocrinology. 13, 831793.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: The FIDELITY pooled analysis

    Agarwal, R., Filippatos, G., Pitt, B., Anker, S. D., Rossing, Peter, Joseph, A., Kolkhof, P., Nowack, C., Gebel, M., Ruilope, L. M. & Bakris, G. L., 2022, In: European Heart Journal. 43, 6, p. 474-484 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. Published

    Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetes

    Ferreira-Divino, L. F., Suvitaival, T., Curovic, V. R., Tofte, N., Trošt, K., Mattila, I. M., Theilade, Karen Simone, Winther, S. A., Hansen, T. W., Frimodt-Møller, M., Legido-Quigley, C. & Rossing, Peter, 2022, In: Cardiovascular Diabetology. 21, 10 p., 135.

    Research output: Contribution to journal › Journal article › Research › peer-review

  14. Published

    Clinical perspective—evolving evidence of mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes

    Rossing, Peter, 2022, In: Kidney International Supplements. 12, 1, p. 27-35 9 p.

    Research output: Contribution to journal › Review › Research › peer-review

  15. Published

    Copeptin and renal function decline, cardiovascular events and mortality in type 1 diabetes

    Heinrich, N. S., Theilade, S., Winther, S. A., Tofte, N., Ahluwalia, Tarun Veer Singh, Jeppesen, J. L., Persson, F., Hansen, T. W., Goetze, Jens P. & Rossing, Peter, 2022, In: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 37, 1, p. 100–107

    Research output: Contribution to journal › Journal article › Research › peer-review

  16. Published

    Correlates and Consequences of an Acute Change in eGFR in Response to the SGLT2 Inhibitor Dapagliflozin in Patients with CKD

    the DAPA-CKD Trial Committees and Investigators, T. D. T. C. A. I., 2022, In: Journal of the American Society of Nephrology. 33, 11, p. 2094-2107 14 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  17. Published

    Dapagliflozin Improves the Urinary Proteomic Kidney-Risk Classifier CKD273 in Type 2 Diabetes with Albuminuria: A Randomized Clinical Trial

    Curovic, V. R., Eickhoff, M. K., Rönkkä, T., Frimodt-Møller, M., Hansen, T. W., Mischak, H., Rossing, Peter, Ahluwalia, Tarun Veer Singh & Persson, F., 2022, In: Diabetes Care. 45, 11, p. 2662-2668 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  18. Published

    Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials

    Rossing, P., Inzucchi, S. E., Vart, P., Jongs, N., Docherty, K. F., Jhund, P. S., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Solomon, S. D., DeMets, D. L., Bengtsson, O., Lindberg, M., Langkilde, A. M., Sjöstrand, M., Stefansson, B. V., Karlsson, C., Chertow, G. M. & 7 others, Hou, F. F., Correa-Rotter, R., Toto, R. D., Wheeler, D. C., McMurray, J. J. V., Heerspink, H. J. L. & DAPA-CKD and DAPA-HF Trial Committees and Investigators, D. A. D. T. C. A. I., 2022, In: The Lancet Diabetes and Endocrinology. 10, 1, p. 24-34 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  19. Published

    Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)

    de Boer, I. H., Khunti, K., Sadusky, T., Tuttle, K. R., Neumiller, J. J., Rhee, C. M., Rosas, S. E., Rossing, Peter & Bakris, G., 2022, In: Diabetes Care. 45, 12, p. 3075-3090

    Research output: Contribution to journal › Journal article › Research › peer-review

  20. Published

    Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)

    de Boer, I. H., Khunti, K., Sadusky, T., Tuttle, K. R., Neumiller, J. J., Rhee, C. M., Rosas, S. E., Rossing, Peter & Bakris, G., 2022, In: Kidney International. 102, 5, p. 974-989 16 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  21. Published

    Diagnostic and prognostic value of the electrocardiogram in stable outpatients with type 2 diabetes

    Gregers, M. C. T., Schou, Morten, Jensen, M. T., Jensen, J., Petrie, M. C., Vilsbøll, Tina, Goetze, Jens P. , Rossing, Peter & Jørgensen, P. G., 2022, In: Scandinavian Cardiovascular Journal. 56, 1, p. 256-263 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  22. Published

    Differential and shared genetic effects on kidney function between diabetic and non-diabetic individuals

    Winkler, T. W., Rasheed, H., Teumer, A., Gorski, M., Rowan, B. X., Stanzick, K. J., Thomas, L. F., Tin, A., Hoppmann, A., Chu, A. Y., Tayo, B., Thio, C. H. L., Cusi, D., Chai, J-F., Sieber, K. B., Horn, K., Li, M., Scholz, M., Cocca, M., Wuttke, M. & 31 others, van der Most, P. J., Yang, Q., Ghasemi, S., Nutile, T., Li, Y., Pontali, G., Günther, F., Dehghan, A., Correa, A., Parsa, A., Feresin, A., de Vries, A. P. J., Zonderman, A. B., Smith, A. V., Oldehinkel, A. J., De Grandi, A., Rosenkranz, A. R., Franke, A., Teren, A., Metspalu, A., Hicks, A. A., Morris, A. P., Tönjes, A., Morgan, A., Podgornaia, A. I., Christensen, K., Lind, L., Kovacs, P., Rossing, Peter, Loos, Ruth & LifeLines Cohort Study, L. C. S., 2022, In: Communications Biology . 5, p. 580 20 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  23. Published

    Distal symmetrical polyneuropathy is present in all individuals with diabetes and foot ulcers - and does not associate with healing time

    Mizrak, H. I., Hansen, T. W., Andersen, Jonas Askø, Rossing, Peter, Rasmussen, A. & Hansen, C. S., 2022, In: Journal of Diabetes and its Complications. 36, 12, 108353.

    Research output: Contribution to journal › Journal article › Research › peer-review

  24. Published

    Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial

    Waijer, S. W., Vart, P., Cherney, D. Z. I., Chertow, G. M., Jongs, N., Langkilde, A. M., Mann, J. F. E., Mosenzon, O., McMurray, J. J. V., Rossing, Peter, Correa-Rotter, R., Stefansson, B. V., Toto, R. D., Wheeler, D. C. & Heerspink, H. J. L., 2022, In: Diabetologia. 65, 7, p. 1085-1097 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  25. Published

    Effect of empagliflozin on myocardial structure and function in patients with type 2 diabetes at high cardiovascular risk: the SIMPLE randomized clinical trial

    Ersbøll, M., Jürgens, M., Hasbak, P., Kjær, Andreas, Wolsk, E., Zerahn, B., Brandt-Jacobsen, N. H., Gæde, P., Rossing, Peter, Faber, Jens, Inzucchi, S. E., Gustafsson, Finn, Schou, Morten & Kistorp, Caroline Michaela Nervil, 2022, In: International Journal of Cardiovascular Imaging. 38, p. 579–587

    Research output: Contribution to journal › Journal article › Research › peer-review

  26. Published

    Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER

    Shaman, A. M., Bain, S. C., Bakris, G. L., Buse, J. B., Idorn, T., Mahaffey, K. W., Mann, J. F. E., Nauck, M. A., Rasmussen, S., Rossing, Peter, Wolthers, B., Zinman, B. & Perkovic, V., 2022, In: Circulation. 145, 8, p. 575-585 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 Next

ID: 12937790